Inhibitory Regulation of Hypertrophy by Endogenous Atrial Natriuretic Peptide in Cultured Cardiac Myocytes

Hypertension

Volumn 35, Issue 1, 2000, Pages 19-

  Horio, Takeshi ^a   Nishikimi, Toshio ^a   Yoshihara, Fumiki ^a   Matsuo, Hisayuki ^a   Takishita, Shuichi ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atrial natriuretic peptide; Autocrine paracrine; Hypertrophy; Myocytes

Indexed keywords

ALPHA ACTIN; CONTRACTILE PROTEIN; CYCLIC GMP; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE TYPE C;

ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; ENZYME ACTIVITY; GENE EXPRESSION; HEART ATRIUM ENLARGEMENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STATISTICAL ANALYSIS;

ACTINS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELL SIZE; CELLS, CULTURED; GENE EXPRESSION; MICE; MYOCARDIUM; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; PHENYLEPHRINE; POLYSACCHARIDES; PROTEIN BIOSYNTHESIS; RATS; RNA, MESSENGER;

EID: 0033954454     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.35.1.19     Document Type: Article

References (32)

1. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985; 313:1330-1340.
2. Needleman P, Greenwald JE. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis. N Engl J Med. 1986; 314:828-834.
3. Garbers DL, Lowe DG. Guanylyl cyclase receptors. J Biol Chem. 1994; 269:30741-30744.
4. Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension. 1995; 25:227-234.
5. Lin X, Hänze J, Heese F, Sodmann R, Lang RE. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res. 1995; 77:750-758.
6. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A. 1997; 94:14730-14735.
7. Calderone A, Thaik CM, Takahashi N, Chang DLF, Colucci WS. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 1998; 101:812-818.
8. Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, Matsuda Y. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun. 1991; 176:949-957.
9. Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H, Sugimoto T. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats: effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Circulation. 1993; 87:554-561.
10. Wada A, Tsutamoto T, Matsuda Y, Kinoshita M. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation. 1994; 89:2232-2240.
11. Nishikimi T, Miura K, Minamino N, Takeuchi K, Takeda T. Role of endogenous atrial natriuretic peptide on systemic and renal hemodynamics in heart failure rats. Am J Physiol. 1994; 267:H182-H186.
12. Nachshon S, Zamir O, Matsuda Y, Zamir N. Effects of ANP receptor antagonists on ANP secretion from adult rat cultured atrial myocytes. Am J Physiol. 1995; 268:E428-E432.
13. Horio T, Nishikimi T, Yoshihara F, Nagaya N, Matsuo H, Takishita S, Kangawa K. Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1β and tumor necrosis factor-α. Endocrinology. 1998; 139:4576-4580.
14. Zheng JS, Boluyt MO, O’Neill L, Crow MT, Lakatta EG. Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ Res. 1994; 74:1034-1041.
15. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation. 1997; 96:3737-3744.
16. 1-adrenergic receptor interaction: evidence for independent regulation of growth and beating. Circ Res. 1985; 56:884-894.
17. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension. 1995; 25:1252-1259.
18. Kim S, Kawamura M, Wanibuchi H, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Iwao H. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation. 1995; 92:88-95.
19. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res. 1995; 77:660-664.
20. Nishikimi T, Horio T, Yoshihara F, Nagaya N, Matsuo H, Kangawa K. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol. 1998; 353:337-344.
21. Aburaya M, Minamino N, Hino J, Kangawa K, Matsuo H. Distribution and molecular forms of brain natriuretic peptide in the central nervous system, heart and peripheral tissue of rat. Biochem Biophys Res Commun. 1989; 165:880-887.
22. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell. 1989; 58:1155-1162.
23. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB. Atrial natriuretic peptide clearance receptor: complete sequence and functional expression of cDNA clones. J Biol Chem. 1988; 263:9395-9401.
24. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995; 267:679-681.
25. Klinger JR, Petit RD, Curtin LA, Warburton RR, Wrenn DS, Steinhelper ME, Field LJ, Hill NS. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol. 1993; 75:198-205.
26. Harding P, Carretero OA, LaPointe MC. Effects of interleukin-1β and nitric oxide on cardiac myocytes. Hypertension. 1995; 25:421-430.
27. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Adachi S, Akimoto H, Marumo F, Hiroe M. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest. 1995; 96:1059-1065.
28. Tsuchimochi H, Kurimoto F, Ieki K, Koyama H, Takaku F, Kawana M, Kimata S, Yazaki Y. Atrial natriuretic peptide distribution in fetal and failed adult human hearts. Circulation. 1988; 78:920-927.
29. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, Takemura G, Fujiwara H, Sugawara A, Yamada T, Itoh H, Mukoyama M, Hosoda K, Kawai C, Ban T, Yasue H, Imura H. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest. 1989; 83:298-305.
30. Takemura G, Fujiwara H, Mukoyama M, Saito Y, Nakao K, Kawamura A, Ishida M, Kida M, Uegaito T, Tanaka M, Matsumori A, Fujiwara T, Imura H, Kawai C. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation. 1991; 83:181-190.
31. Lee RT, Bloch KD, Pfeffer JM, Pfeffer MA, Neer EJ, Seidman CE. Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest. 1988; 81:431-434.
32. Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology. 1996; 137:817-824.